“Survival after postoperative combination treatment of rectal cancer.”, N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
, “Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum.”, Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
, “Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies.”, NCI Monogr, no. 5, pp. 179-84, 1987.
, “Current status and future directions of clinical trials in chronic lymphocytic leukemia.”, Oncology (Williston Park), vol. 1, no. 8, pp. 31-40, 44, 1987.
, “The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group.”, Am J Gastroenterol, vol. 82, no. 8, pp. 738-43, 1987.
, “Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.”, N Engl J Med, vol. 317, no. 23, pp. 1433-8, 1987.
, “The 1987 USA National CAPD Registry report.”, ASAIO Trans, vol. 34, no. 2, pp. 150-6, 1988.
, “Current concepts. Continuous ambulatory peritoneal dialysis.”, N Engl J Med, vol. 318, no. 24, pp. 1595-600, 1988.
, “A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy.”, J Diabet Complications, vol. 2, no. 4, pp. 227-32, 1988.
, “Mesothelioma in Cyprus.”, IARC Sci Publ, no. 90, pp. 411-9, 1989.
, “The Mid-Atlantic Oncology Program's comparison of two data collection methods.”, Control Clin Trials, vol. 10, no. 3, pp. 282-9, 1989.
, “Rilmenidine and vigilance. Review of clinical studies.”, Am J Med, vol. 87, no. 3C, p. 67S-72S, 1989.
, “Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry.”, Am J Kidney Dis, vol. 14, no. 1, pp. 44-9, 1989.
, “Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase.”, J Med Chem, vol. 33, no. 2, pp. 543-52, 1990.
, “Challenges of HIV vaccine development.”, Stat Med, vol. 9, no. 12, pp. 1425-31; discussion 1433-7, 1990.
, “Hematocrit values in the CAPD/CCPD population: a report of the National CAPD Registry.”, Perit Dial Int, vol. 10, no. 4, pp. 275-8, 1990.
, “Assessment of family history information in case-control cancer studies.”, Am J Epidemiol, vol. 133, no. 8, pp. 757-65, 1991.
, “Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error.”, Biometrics, vol. 47, no. 2, pp. 523-33, 1991.
, “Assessing quality of life in head and neck cancer.”, Qual Life Res, vol. 1, no. 1, pp. 5-17, 1992.
, “Building quality of life assessment into cancer treatment studies.”, Oncology (Williston Park), vol. 6, no. 6, pp. 25-8; discussion 30-2, 37, 1992.
, “Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.”, J Natl Cancer Inst, vol. 84, no. 8, pp. 575-9, 1992.
, “Recovery of renal function in continuous ambulatory peritoneal dialysis: a study of National CAPD Registry data.”, Perit Dial Int, vol. 12, no. 1, pp. 43-7, 1992.
, “Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.”, J Med Primatol, vol. 21, no. 2-3, pp. 139-86, 1992.
, “First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.”, J Med Primatol, vol. 22, no. 2-3, pp. 203-35, 1993.
, “Five-year patient and graft survival in North American children: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Kidney Int Suppl, vol. 43, pp. S16-21, 1993.
,